GPX4 and cancer: As highlighted by Nakamura and Conrad [57], simultaneous targeting of multiple ferroptosis-related pathways, such as the GPX4 and FSP1 axes, may provide a more potent strategy for ferroptosis induction in cancer cells, particularly in therapy-resistant malignancies.